Series C - Abridge

Series C - Abridge

Investment Firm

Overview

Abridge is a medical conversation AI startup that structures and summarizes medical conversations for doctors and patients.

Announced Date

Feb 23, 2024

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Redpoint

Redpoint

Redpoint is a early_stage_venture and late_stage_venture and seed and venture firm.

Lightspeed Venture Partners

Lightspeed Venture Partners

Lightspeed Venture Partners is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

9

Investor Name
Participant InvestorLightspeed Venture Partners
Participant InvestorIVP
Participant InvestorBessemer Venture Partners
Participant InvestorRedpoint
Participant InvestorSpark Capital

Round Details and Background

Abridge raised $150000000 on 2024-02-23 in Series C

Abridge is a medical conversation AI startup that structures and summarizes medical conversations for doctors and patients.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 11, 2022
Series A - Abridge
7-12.5M
May 18, 2023
Corporate Round - Abridge
1-undefined
Oct 26, 2023
Series B - Abridge
9-30.0M
Feb 23, 2024
Series C - Abridge
10-150.0M

Recent Activity

There is no recent news or activity for this profile.